The largest database of trusted experimental protocols

Pcmv6neo

Manufactured by OriGene
Sourced in United States

The PCMV6NEO is a plasmid vector that contains the neomycin resistance gene under the control of the cytomegalovirus (CMV) promoter. It can be used for the selection of mammalian cells transfected with the vector.

Automatically generated - may contain errors

4 protocols using pcmv6neo

1

Overexpression Assay of EPAC1 and EPAC2

Check if the same lab product or an alternative is used in the 5 most similar protocols
We obtained MYC tagged-EPAC1 from Dr. Stephen J Yarwood of Heriot-Watt University, Edinburgh, UK and DDK tagged-EPAC2 (#RC205335) from Origene (Rockville, MD). 2.5x105 cells/ml in triplicate wells in 6-well plates were transfected with 5μg empty vector plasmid (#PCMV6NEO, Origene, Rockville, MD) or MYC tagged-EPAC1 or DDK tagged-EPAC2 plasmids using Lipofectamine™ RNAiMAX (Thermo Fisher Scientific, Waltham, MA) in reduced serum Opti-MEM. The medium was changed 16 hours post transfection, and the cells were maintained in Geneticin (G418 2.5mg/ml) containing medium. Cells were lysed 5 days post- transfection and protein expression was analyzed by western blot using anti-Myc and ant-DDK antibodies. Bulk transfected cells were trypsinized and plated in 6 replicate wells (5,000 cells/well) in multiple 96-well plates and the cell growth was assessed using MTT assay.
+ Open protocol
+ Expand
2

Overexpression of AEG-1 in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 6-well culture plates at a density of 1.5 × 105 per well in 2 ml complete culture medium. After 24 h, the cells were transfected with 1.5 μg of either pCMV6-Neo (Origene, Rockville, MD, USA) or with pCMV6-Neo MTDH (Origene, NM_178812, CW101031) using X-tremeGENE 9 (Roche Diagnostic Corporation, Indianapolis, IN, USA) according to the manufacturer's instructions. After 24 h, fresh medium was added to the cells or the cells were seeded for follow-up experiments. Upregulation of AEG-1 was confirmed by qPCR (Supplementary Materials and Methods) and western blot (Supplementary Figure 2).
+ Open protocol
+ Expand
3

Cyclin D1 and ETV4 Regulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibody against Cyclin D1 (rabbit polyclonal) was purchased from Cell Signaling Technology (Beverly, MA). Anti -ETV4 (rabbit polyclonal) antibody and respective anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibodies were procured from Santa Cruz Biotechnology (Santa Cruz, CA). The β-actin (mouse monoclonal) antibody was purchased from Sigma-Aldrich (St. Louis MO). ETV4 knockdown short hairpin RNA (shRNA) expression constructs (pGFP-V-RS-shETV4) along with scrambled control (pGFP-V-RS-NTScr) and ETV4 overexpression construct (pCMV6-ETV4) and scramble control (pCMV6-Neo) were purchased from Origene (Rockville, MD). Cyclin D1 overexpression construct (pCMV6-CCND1) and control vector (pCMV6) were also purchased from Origene.
+ Open protocol
+ Expand
4

Cloning and Mutagenesis of URAT1 Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
hURAT1 (GenBank BC053348.1), rURAT1 (NCBI NM_001034943.1), and mURAT1 (NCBI NM_009203) genes were purchased from Origene Technologies, Inc. hURAT1 and rURAT1 were subcloned into pCMV6/neo using NotI, creating pCMV6/neo-hURAT1 and pCMV6/neo-rURAT1. Point mutants were produced by polymerase chain reaction or site-directed mutagenesis using the QuikChange Lightning Multi Site Directed Mutagenesis Kit (Agilent Technologies), using mutagenic primers shown in supplementary table S1, Supplementary Material online. All mutants were confirmed by DNA sequencing. Ancestral and baboon URAT1 sequences were synthesized by Blue Heron Biotech, LLC and cloned into pCMV6/neo using EcoRI and XbaI. All URAT1 protein sequences are show in supplementary figure S2, Supplementary Material online.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!